During the past decade, Advanced Diagnostic Pain Treatment Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Diagnostic Pain Treatment Center" #1 collaborator was "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Diagnostic Pain Treatment Center" are "Opioid-Induced Bowel Dysfunction" (2 trials), "Breakthrough Pain" (1 trials), "Chronic Pain" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "Advanced Diagnostic Pain Treatment Center" in a lesser frequency.

Most popular intervention types in "Advanced Diagnostic Pain Treatment Center" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Fentanyl Buccal Tablets" (1 trials), "Lubiprostone" (1 trials), "Lubiprostone 24" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Diagnostic Pain Treatment Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Diagnostic Pain Treatment Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Advanced Diagnostic Pain Treatment Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Diagnostic Pain Treatment Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".